The disease spectrum of coronavirus disease 2019 (COVID‐19) varies from asymptomatic
infection to critical illness and death. Identification of prognostic markers is vital for predicting …

Objective: The clinical implications of SARS-CoV-2 RNA viremia in blood (RNAemia) remain
uncertain despite gaining more prognostic implications for coronavirus disease 2019 …

Background This study aimed to clarify how SARS-CoV-2 RNAemia is related to COVID-19
critical condition development and mortality in comparison with other predictive markers and …

Background Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA in blood, also known as RNAemia, has been reported, but its prognostic implications …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA loads in
patient specimens may act as a clinical outcome predictor in critically ill patients with …

This study aimed to determine the frequency of SARS‐CoV‐2 RNA in serum and its
association with the clinical severity of COVID‐19. This retrospective cohort study performed …

Background The determinants of coronavirus disease 2019 (COVID-19) disease severity
and extrapulmonary complications (EPCs) are poorly understood. We characterized …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19). This study aimed to determine if SARS-CoV-2 RNA …

Abstract Determinants of Post-Acute Sequelae of COVID-19 are not known. Here we show
that 83.3% of patients with viral RNA in blood (RNAemia) at presentation were symptomatic …

Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. All rights reserved. For …